Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
Study NCT ID:
NCT06614192
Status:
RECRUITING
Last Update Posted:
2025-08-26
First Post:
2024-09-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-25
First Submit QC Date:
None
Study First Post Date:
2024-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-22
Last Update Post Date:
2025-08-26
Last Update Post Date Type:
ESTIMATED